Dissemination and Implementation Science Pilot Awards (DISPA)
The Clinical and Translational Science Institute (CTSI) at the University of Pittsburgh is now seeking applications for Dissemination and Implementation Science Pilot Awards (DISPA).
Dissemination research is defined as “the scientific study of targeted distribution of information and intervention materials to a specific public health or clinical practice audience. The intent is to understand how best to communicate and integrate knowledge and the associated evidence-based interventions.” (National Institutes of Health (NIH) 2021)
Implementation research is defined as "the scientific study of the use of strategies to adopt and integrate evidence-based health interventions into clinical and community settings to improve individual outcomes and benefit population health.” (NIH 2021)
The goal of dissemination and implementation (D&I) research is to shorten the often-stated 17-year evidence to practice gap. D&I research aims to translate evidence to positively impact individuals and communities, healthcare delivery and financing, or policy. D&I research engages essential partners with relevant experience such as patients, the public (e.g., families, informal caregivers), providers, payers, and policymakers. Inherent in D&I research is ensuring equitable dissemination and implementation of evidence-based practices to all who would benefit.
These pilot awards will support:
- D&I research projects that examine some aspect of disseminating, adopting, implementing, or maintaining an evidence-based practice or program, or
- Other types of research projects (g., an effectiveness study or intervention development study) that include a focus on some aspect of dissemination or implementation
Round 1 Submission Deadline:
Friday, August 25, 2023, by 11:59:59 p.m. EDT
Notification to Advancing Investigators:
Monday, September 11, 2023
Round 2 Submission Deadline:
Friday, October 6, 2023, by 11:59:59 p.m. EDT
Notification to Awardees:
Monday, October 30, 2023
Anticipated Start Date:
January 1, 2024
Award funding of $50,000 is available to cover direct costs. No indirect support will be provided. The award period is 12 months. The DISPA pilots do not have any mechanism for no-cost extensions; any funds that are not spent during the award period will be forfeited.
Before the start of the award period, awardees must provide documentation of all necessary regulatory approvals. Once regulatory documentation is provided, awarded projects will undergo an administrative review from the National Center for Advancing Translational Sciences (NCATS) which is the National Institutes of Health (NIH) Institute that funds the University of Pittsburgh CTSI. Funding cannot begin until projects have been approved by NCATS. Because the NCATS review may take up to 30 days, applicants are strongly encouraged to have the necessary regulatory documents ready for submission.
The Principal Investigator (PI) must be a University of Pittsburgh faculty member; postdoctoral trainees and trainees in clinical training programs are not eligible to serve as PI. Faculty members on early-career training awards or clinical research scholars (i.e., recipients of K-series or similar career development grants) are eligible. New PIs are strongly encouraged to apply, but submissions from established investigators will be accepted if there is clear evidence that the pilot project represents a distinctly new direction from their previously funded work.